2604
E. Tayama et al. / Tetrahedron: Asymmetry 20 (2009) 2600–2608
55.8, 55.7, 49.4, 27.9; IR (film) 3336, 2968, 1726, 1600, 1440, 1366,
1238, 1146, 1018, 832, 724 cmꢁ1; Anal. Calcd for C17H31ClNO5.5: C,
54.76; H, 8.38; N, 3.76. Found: C, 54.71; H, 8.31; N, 3.48.
solution of potassium tert-butoxide (0.15 mL, 0.15 mmol). The
mixture was stirred for 6 h at the same temperature under an ar-
gon atmosphere. The resulting mixture was added to a stirred,
ice-cold solution of saturated aqueous ammonium chloride, and
the mixture was extracted with ether. The combined extracts were
washed with saturated aqueous sodium hydrogen carbonate and
brine, dried over sodium sulfate, and concentrated. Purification of
the residue by chromatography on silica gel (hexane/ethyl ace-
tate = 1:1 as eluent) gave 4c (20.7 mg, 62% yield) as a colorless
oil. The ee was determined to be 60% ee by HPLC analysis [Daicel
Chiralpak AD-H column, n-hexane/ethanol = 95:5 as eluent, flow
rate = 0.50 mL/min, tR = 20.9 min for the (S)-isomer and 27.6 min
for (R)-isomer].
4.2.9. (R)-N-(tert-Butoxycarbonylmethyl)-N-(2-hydroxyethyl)-
N-methyl-N-[2-(trifluoromethyl)benzyl]ammonium bromide
(R)-1g
25
589
White solid; ½
a
ꢀ
¼ þ6:2 (c 1.00, EtOH); 80% ee [determined by
HPLC analysis: Daicel Chiralcel OD-H column, n-hexane/ethanol/
trifluoroacetic acid/diethylamine = 95:5:0.1:0.1 as eluent, flow
rate = 0.50 mL/min, tR = 17.9 min for the (S)-1g and 21.5 min for
(R)-1g]; 1H NMR (270 MHz, CDCl3) d 8.15 (1H, d, J = 7.6 Hz, Ar-H),
7.84 (1H, d, J = 7.6 Hz, Ar-H), 7.76 (1H, dd, J = 7.6, 7.6 Hz, Ar-H),
7.68 (1H, dd, J = 7.6, 7.6 Hz, Ar-H), 5.51 (1H, d, J = 13.6 Hz,
CH2COO), 5.41 (1H, dd, J = 13.6 Hz, CH2COO), 5.05 (1H, br, OH),
4.85 (1H, d, J = 17.0 Hz, CH2Ar), 4.61 (1H, d, J = 17.0 Hz, CH2Ar),
4.35–4.11 (3H, m, CH2CH2OH), 3.75–3.60 (1H, m, CH2CH2OH),
3.49 (3H, s, NCH3), 1.52 (9H, s, t-Bu); 13C NMR (68 MHz, CDCl3) d
163.3, 136.8, 132.4, 131.2, 131.0 (q, J = 30 Hz), 127.7 (q, J = 5 Hz),
124.6, 123.5 (q, J = 275 Hz), 85.0, 63.4, 63.1, 60.2, 55.3, 49.4, 27.6;
IR (film) 3300, 2960, 1732, 1602, 1580, 1450, 1392, 1368, 1300,
1242, 1146, 1120, 1036, 894, 832, 724 cmꢁ1; Anal. Calcd for
C17H25BrF3NO3: C, 47.67; H, 5.88; N, 3.27. Found: C, 47.69; H,
6.09; N, 3.22.
4.2.13. (S)-4-Methyl-3-(2-methylbenzyl)morpholin-2-one (S)-4c
and (S)-4l
22
589
Colorless oil; ½
aꢀ
¼ þ4:0 (c 1.00, EtOH); 60% ee (determined
by HPLC); 1H NMR (270 MHz, CDCl3) d 7.34–7.08 (4H, m, Ar-H),
4.23 (1H, ddd, J = 10.9, 3.0, 3.0 Hz, 6-H), 4.11 (1H, ddd, J = 10.9,
10.2, 3.0 Hz, 6-H), 3.45 (1H, dd, J = 5.8, 4.9 Hz, 3-H), 3.22 (1H, dd,
J = 14.5, 4.9 Hz, CH2Ar), 3.14 (1H, dd, J = 14.5, 5.8 Hz, CH2Ar), 2.89
(1H, ddd, J = 12.9, 3.0, 3.0 Hz, 5-H), 2.64 (1H, ddd, J = 12.9, 10.2,
3.0 Hz, 5-H), 2.37 (3H, s, NCH3 or ArCH3), 2.31 (3H, s, NCH3 or
ArCH3); 13C NMR (68 MHz, CDCl3) d 170.5, 136.9, 136.1, 130.11,
130.07, 126.5, 125.6, 67.22, 67.16, 50.3, 43.5, 34.5, 19.8; IR (film)
2940, 2848, 2788, 1726, 1488, 1452, 1402, 1368, 1334, 1288,
1184, 1146, 1056, 932, 740 cmꢁ1; Anal. Calcd for C13H17NO2: C,
71.21; H, 7.81; N, 6.39. Found: C, 71.12; H, 7.84; N, 6.46.
4.2.10. (R)-N-(2-Hydroxyethyl)-N-(methoxycarbonylmethyl)-N-
methyl-N-(2-methylbenzyl)ammonium bromide, 0.5 hydrate
(R)-1l
22
589
White solid; 8:2 mixture of rotamers; ½
a
ꢀ
¼ þ8:3 (c 1.00,
EtOH); 81% ee (determined by specific rotation, using triply-re-
solved material to give a standard specific rotation with ca. 5% er-
ror); 1H NMR (270 MHz, CDCl3) d 7.74 (0.2H, d, J = 7.4 Hz, Ar-H),
7.58 (0.8H, d, J = 7.4 Hz, Ar-H), 7.45–7.23 (3H, m, Ar-H), 5.52
(0.2H, d, J = 13.1 Hz, CH2COO), 5.44 (0.2H, d, J = 13.1 Hz, CH2COO),
5.26 (1.6H, s, CH2COO), 5.14 (0.8H, d, J = 17.4 Hz, CH2Ar), 5.03
(0.8H, d, J = 17.4 Hz, CH2Ar), 4.97–4.49 (1.4H, m, CH2Ar and OH),
4.42–4.03 (3H, m, CH2CH2OH), 3.79 (3H, s, OCH3 or NCH3), 3.69–
3.55 (1H, m, CH2CH2OH), 3.52 (0.6H, s, OCH3 or NCH3), 3.46
(2.4H, s, OCH3 or NCH3), 2.63 (0.6H, s, ArCH3), 2.56 (2.4H, s, ArCH3);
13C NMR (68 MHz, CDCl3) d 165.2 (0.8C), 160.4 (0.2C), 140.0 (0.2C),
139.9 (0.8C), 134.3 (0.2C), 134.1 (0.8C), 131.6 (0.2C), 131.5 (0.8C),
130.8 (0.2C), 130.5 (0.8C), 126.2 (0.2C), 126.1 (0.8C), 124.8 (0.8C),
123.8 (0.2C), 66.0 (0.2C), 64.8 (0.8C), 62.4 (0.2C), 61.5 (0.8C), 58.9
(0.8C), 58.5 (0.2C), 54.9 (1.0C), 53.7 (0.2C), 52.6 (0.8C), 48.1
(0.8C), 47.4 (0.2C), 20.2 (0.2C), 20.1 (0.8C); IR (film) 3280, 2948,
1742, 1602, 1438, 1262, 1222, 1086, 1000, 886, 722 cmꢁ1; Anal.
Calcd for C14H23BrNO3.5: C, 49.28; H, 6.79; N, 4.10. Found: C,
49.12; H, 6.56; N, 4.04.
4.2.14. (S)-3-Benzyl-4-methylmorpholin-2-one (S)-4b
25
589
Colorless oil; ½
a
ꢀ
¼ þ6:1 (c 1.00, EtOH); 56% ee [determined
by HPLC analysis: Daicel Chiralpak AD–H column, n-hexane/etha-
nol = 95:5 as eluent, flow rate = 0.50 mL/min, tR = 20.4 min for the
(S)-4b and 28.4 min for (R)-4b]; 1H NMR (270 MHz, CDCl3) d
7.35–7.17 (5H, m, Ph), 4.13 (1H, ddd, J = 10.8, 2.7, 2.7 Hz, 6-H),
3.96 (1H, ddd, J = 10.8, 10.8, 2.7 Hz, 6-H), 3.38 (1H, dd, J = 4.6,
4.3 Hz, 3-H), 3.26 (1H, dd, J = 14.3, 4.3 Hz, CH2Ph), 3.13 (1H, dd,
J = 14.3, 4.6 Hz, CH2Ph), 2.82 (1H, ddd, J = 12.6, 2.7, 2.7 Hz, 5-H),
2.63 (1H, ddd, J = 12.6, 10.8, 2.7 Hz, 5-H), 2.42 (3H, s, NCH3); 13C
NMR (68 MHz, CDCl3) d 170.1, 137.4, 129.9, 128.0, 126.5, 68.0,
67.4, 50.6, 43.1, 36.4; IR (film) 3020, 2944, 2844, 2788, 1726,
1600, 1490, 1450, 1402, 1368, 1334, 1290, 1180, 1144, 1056,
934, 746, 696 cmꢁ1; Anal. Calcd for C12H15NO2: C, 70.22; H, 7.37;
N, 6.82. Found: C, 69.92; H, 7.31; N, 6.79.
4.2.15. (S)-3-(2-Methoxybenzyl)-4-methylmorpholin-2-one (S)-
4e and (S)-4f
25
589
Colorless oil; ½
a
ꢀ
¼ þ12:0 (c 1.00, EtOH); 50% ee [determined
by HPLC analysis: Daicel Chiralpak AD–H column, n-hexane/etha-
nol = 95:5 as eluent, flow rate = 0.50 mL/min, tR = 25.8 min for the
(S)-isomer and 31.0 min for (R)-isomer]; 1H NMR (270 MHz, CDCl3)
d 7.28–7.16 (2H, m, Ar-H), 6.93–6.81 (2H, m, Ar-H), 4.30–4.15 (2H,
m, 6-H), 3.81 (3H, s, OCH3), 3.41–3.24 (2H, m, 3-H and CH2Ar), 3.18
(1H, dd, J = 14.2, 6.6 Hz, CH2Ar), 2.83 (1H, ddd, J = 12.8, 3.0, 3.0 Hz,
5-H), 2.61 (1H, ddd, J = 12.8, 8.4, 5.0 Hz, 5-H), 2.33 (3H, s, NCH3);
13C NMR (68 MHz, CDCl3) d 170.6, 157.7, 131.0, 127.7, 126.2,
120.2, 110.0, 67.3, 66.3, 54.8, 50.5, 43.1, 31.9; IR (film) 2940,
2828, 2784, 1722, 1598, 1584, 1488, 1452, 1402, 1334, 1290,
1238, 1182, 1146, 1110, 1026, 932, 804, 746 cmꢁ1; Anal. Calcd
for C13H17NO3: C, 66.36; H, 7.28; N, 5.95. Found: C, 66.15; H,
7.41; N, 5.92.
4.2.11. Determination of the absolute configuration of 1l
The absolute configuration of 1l was determined as (R) on the
nitrogen atom by a single crystal X-ray diffraction of a 1:1 complex
2l (Fig. 1). Recrystallization of 2l from methanol–diethyl ether gave
a single crystal which was suitable for crystallographic analysis.7
Crystal data of 2l: C34H36BrNO5, MW = 618.57; monoclinic; space
group P21 (#4); a = 9.1803(2) Å, b = 13.3010(4) Å, c = 12.6018(4) Å,
b = 101.267(2)°; V = 1509.11(8) Å3; Z = 2; Dcalcd = 1.361 g/cm3;
l
= 14.08 cmꢁ1; 2hmax = 60.1°; T = 296 K; R1 (I > 2
r(I)) = 0.045; wR2
(all data) = 0.102; GOF = 1.16 for 8210 reflections and 370 parame-
ters. The absolute structure was determined based on Flack param-
eter, 0.001(7), refined using 3823 Friedel pairs.
4.2.12. Representative procedure for the rearrangement of N-
chiral tetraalkylammonium salt (R)-1c
A solution of (R)-1c (58.6 mg, 0.153 mmol, 94% ee) in acetoni-
trile (1.5 mL) was cooled to ꢁ30 °C and treated with a 1.0 M THF
4.2.16. 2-[N-(2-Hydroxyethyl)-N-methylamino]-2-[2-methyl-3-
(trifluoromethyl)phenyl]acetic acid tert-butyl ester 5g
23
589
Colorless oil; ½
aꢀ
¼ þ5:8 (c 1.00, EtOH); 11% ee [determined by
HPLC analysis: Daicel Chiralpak AD-H column, n-hexane/isopropanol =